EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention

Maxime Villiet, Marion Laureau, Damien Perier, Véronique Pinzani, Isabelle Giraud, Laura Lohan, Xavier Bobbia, Grégoire Mercier, Audrey Jaussent, Valérie Macioce, Mustapha Sebbane, Marie Faucanié und 1 weitere

JAMA Internal Medicine · 2025

DOI: 10.1001/jamainternmed.2025.0640 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Internal Medicine, 2025. Verfasst von Maxime Villiet und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, Montpellier, France. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Emergency Service, Hospital, Pharmacists. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Medication-related events (MREs) are a frequent cause of emergency department (ED) visits and patient harm.

Objective

To assess the efficacy of a pharmacist-led transition of care program in reducing ED visits related to the same MRE at 6 months compared with usual care. Design, Setting, and Participants This prospective, open-label, parallel-group randomized clinical trial was conducted from November 2018 to July 2021 at the ED of Montpellier University Hospital, Montpellier, France, with a 6-month follow-up period. Adult patients with an MRE detected at ED admission were included. MREs included adverse drug events with or without misuse and medication nonadherence with unfavorable clinical evolution. End points were assessed blindly from the randomization arm. Data were analyzed from January 2022 to March 2024.

Intervention

Participants were randomized to a pharmacist-led transition of care program or usual care. Usual care included the ED pharmacist carrying out a medication history. In the transition of care group, ED pharmacists additionally made a postdischarge telephone call to the general practitioner (GP) and community pharmacist, along with a letter, notifying them about MRE type, suspected medication, and management recommendations. Main Outcomes and Measures The primary outcome was the proportion of patients with an ED visit for the same MRE at 6 months (same symptom and medication involved). Secondary outcomes included proportions of all-cause and MRE-related ED visits, hospitalizations, deaths, and medical office visits.

Results

Among 330 patients analyzed, 187 (56.7%) were female, the median (IQR) age was 71 (50-83) years, and the median (IQR) home medications count was 6 (3-10). A total of 167 patients were randomized to the transition of care group and 163 to the control group. At 6 months, fewer participants in the transition of care group had ED visits related to the same MRE (5 [3.0%] vs 36 [22.1%]; risk difference [RD], −19.1 percentage points; 95% CI, −26.0 to −12.2; P < .001), all-cause ED visits (35 [21.0%] vs 57 [35.0%]; RD, −14.0 percentage points; 95% CI, −23.6 to −4.4), hospitalization related to the same MRE (3 [1.8%] vs 29 [17.8%]; RD, −16.0 percentage points; 95% CI, −22.2 to −9.8), and more GP office visits (88 of 158 [55.7%] vs 26 of 146 [17.8%]; RD, 37.9 percentage points; 95% CI, 28.0 to 47.8) and specialist office visits (67 of 158 [42.4%] vs 35 of 146 [24.0%]; RD, 18.4 percentage points; 95% CI, 8.1 to 28.8) related to the same MRE. All-cause hospitalization and death were similar between groups. Conclusions and Relevance In this randomized clinical trial, a pharmacist-led transitional care intervention in the ED among patients with MRE significantly reduced ED visits and hospitalizations for the same MRE. If replicated in subsequent trials, this strategy offers a novel approach for reducing drug-related harms. Trial Registration ClinicalTrials.gov Identifier: NCT03725046

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Related Side Effects and Adverse ReactionsEmergency Service, HospitalPharmacistsAgedFemaleHumansMaleMiddle AgedEmergency Room VisitsFranceProspective Studies

Autor:innen und Institutionen

  • Clinical Pharmacy Department, CHU Montpellier, University of Montpellier, Montpellier, France.
  • Emergency Medicine Department, CHU Montpellier, University of Montpellier, Montpellier, France.
  • Medical Pharmacology and Toxicology Department, CHU Montpellier, University of Montpellier, Montpellier, France.
  • Economic Evaluation Unit, CHU Montpellier, University of Montpellier, Montpellier, France.
  • PhyMedExp, University of Montpellier, CNRS, INSERM, Montpellier, France.
  • Department of Emergency Medicine, UR UM 103 (IMAGINE), Montpellier University, Montpellier University Hospital, Montpellier, France.

Zitieren

APA

Villiet, M., Laureau, M., Perier, D., Pinzani, V., Giraud, I., Lohan, L., Bobbia, X., Mercier, G., Jaussent, A., Macioce, V., Sebbane, M., Faucanié, M., & Breuker, C. (2025). Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.0640

Vancouver

Villiet M, Laureau M, Perier D, Pinzani V, Giraud I, Lohan L, et al. Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention. JAMA Internal Medicine. 2025. doi:10.1001/jamainternmed.2025.0640

BibTeX
@article{Villiet2025,
  author = {Villiet, Maxime and Laureau, Marion and Perier, Damien and Pinzani, Véronique and Giraud, Isabelle and Lohan, Laura and Bobbia, Xavier and Mercier, Grégoire and Jaussent, Audrey and Macioce, Valérie and Sebbane, Mustapha and Faucanié, Marie and Breuker, Cyril},
  title = {Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention},
  journal = {JAMA Internal Medicine},
  year = {2025},
  doi = {10.1001/jamainternmed.2025.0640}
}
Kostenlos starten →